Adheris is the leading provider of
patient adherence intervention programs


About Adherence

  The problem of non-adherence
    Over the last 80 years, the disease burden imposed on Western nations has shifted from acute life-threatening illnesses to chronic degenerative disorders. Today, the leading causes of morbidity and mortality in the U.S. are chronic diseases such as hypertension, high cholesterol, asthma, and diabetes. The effects of chronic diseases often accumulate slowly over decades.

    Consequently, the burden of routine care has migrated from the doctor to the patient through the disarmingly simple necessity of having to take a pill--often daily--over months, years, or decades.

    The symptoms of chronic diseases may be entirely silent, as with high cholesterol; or only episodically apparent, as with asthma and diabetes. Painful or life-threatening complications may still lie in wait decades away. Treatment occurs in the outpatient arena, typically at home. While the doctor still establishes the diagnosis and initiates treatment, the patient has become responsible for the daily delivery of care. Adheris was founded to address the problems associated with this fundamental shift in health care treatment.

  Who benefits from improved adherence?

Patients
    First and foremost, the patient benefits from a better quality of life.  Adherence improves therapeutic outcomes, allowing the patient to experience the intended effects of a prescribed medication.

Businesses
    Improved health status leads to a more productive lifestyle, and businesses benefit from healthy employees. Improved adherence can reduce the number of
  • Hospital admissions
  • Emergency room visits
  • Sick days, which cost industries billions of dollars annually
Everyone
    We all benefit if we can reduce the overall costs to the U.S. health care system linked to prescription non-adherence.
Health Implications
  • Adherence averages 50 percent in developed nations across therapeutic categories,
  • The consequences of poor adherence are poor health outcomes and increased health care costs
  • Across diseases, adherence is the single most important modifiable factor compromising treatment outcome
  • Adherence is a dynamic process, requiring patient tailored interventions and careful follow-up


Incredibly...
  • Nearly half of all patients in developed nations stop taking their medication within the first six months of prescribed therapy.
  • Some patients don't understand what kinds of benefits they should expect from their medication, how the medicine helps them, or even how long they should remain on therapy.
  • This non-adherence results in an increase in hospitalization for many, and sharply increased health care costs for all.
Adheris empowers patients to make informed health care decisions by getting relevant educational information into their hands at specific decision points (or milestones) throughout their therapy.